Article

AJMC® in the Press, December 9, 2022

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A piece by HealthITAnalytics cited a study pubished in the December 2022 issue of The American Journal of Managed Care® (AJMC®). The study, “On the Impact of Predictive Analytics–Driven Disease Management Interventions,” showed that predictive analytics–driven disease management outperforms standard of care among patients with chronic heart failure.


An article by Wired referenced a study published in a 2016 supplement to AJMC®, titled “Economic Costs of Hemophilia and the Impact of Prophylactic Treatment on Patient Management.” The study indicated that intravenous infusions for the management of hemophilia cost patients an average of $127,194 per year.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
 Khush Kharidia, MD, UT Southwestern
Alexandra M. Trevino, MD, Northwestern Medicine
Dr Carla Nester
AJMC interview with Ali Shan Hafeez and Dr Abdul Rafae Faisal | Background image credit: ipopba - stock.adobe.com
2 experts in this video
2 experts in this video
Marry Vuong, PharmD, BCPPS
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo